The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis

OBJECTIVE: To investigate the efficacy of minodronate in the treatment of glucocorticoid-induced osteoporosis (GIO). METHODS: The study population included patients in whom the administration of minodronate (50 mg, once every 4 weeks) had been newly started for the treatment of GIO in Niigata Rheuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Eriko, Ito, Satoshi, Takai, Chinatsu, Kobayashi, Daisuke, Nomura, Yumi, Otani, Hiroshi, Abe, Asami, Ishikawa, Hajime, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120818/
https://www.ncbi.nlm.nih.gov/pubmed/29607978
http://dx.doi.org/10.2169/internalmedicine.9885-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120818/
https://www.ncbi.nlm.nih.gov/pubmed/29607978
http://dx.doi.org/10.2169/internalmedicine.9885-17

Ejemplares similares